Cargando…
Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy
Mutations in the CDKL5 gene lead to an incurable rare neurological condition characterized by the onset of seizures in the first weeks of life and severe intellectual disability. Replacement gene or protein therapies could represent intriguing options, however, their application may be inhibited by...
Autores principales: | Balestra, Dario, Giorgio, Domenico, Bizzotto, Matteo, Fazzari, Maria, Ben Zeev, Bruria, Pinotti, Mirko, Landsberger, Nicoletta, Frasca, Angelisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747535/ https://www.ncbi.nlm.nih.gov/pubmed/31450582 http://dx.doi.org/10.3390/ijms20174130 |
Ejemplares similares
-
Not Just Loss-of-Function Variations: Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution
por: Frasca, Angelisa, et al.
Publicado: (2022) -
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
por: Fernandez Alanis, Eugenio, et al.
Publicado: (2012) -
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I
por: Balestra, Dario, et al.
Publicado: (2020) -
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing Mutants
por: Balestra, Dario, et al.
Publicado: (2016) -
The Somatic FAH c.1061C>A Change Counteracts the Frequent FAH c.1062+5G>A Mutation and Permits U1snRNA-Based Splicing Correction
por: Scalet, Daniela, et al.
Publicado: (2018)